Differences in teratogenicity of some vitamin K antagonist substances used as human therapeutic or rodenticide are due to major differences in their fate after an oral administration
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 333, 71-79
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Impact of Lymphatic Transport on the Systemic Disposition of Lipophilic DrugsJournal of Pharmaceutical Sciences, 2013
- Warfarin: almost 60 years old and still causing problemsBritish Journal of Clinical Pharmacology, 2006
- Of rats and men: superwarfarin toxicityThe Lancet, 2005
- Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in manJournal of Pharmaceutical Sciences, 2003
- Warfarin metabolites: Stereochemical aspects of protein binding and displacement by phenylbutazoneChirality, 1993
- The warfarin embryopathy: A rat model showing maxillonasal hypoplasia and other skeletal disturbancesTeratology, 1992
- The plasma volume of the Wistar rat in relation to the body weightCellular and Molecular Life Sciences, 1981
- Effect of Altered Plasma Protein Binding on Apparent Volume of DistributionJournal of Pharmaceutical Sciences, 1979
- Protein binding of warfarin enantiomers in serum of humans and ratsJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albuminJournal of Clinical Investigation, 1969